Lipid Balance in Adult Sickle Cell Patients

Plain-language summary

This study examines lipid (fat) balance and HDL2 levels in adults with sickle cell disease. It enrolled patients aged 18 and older living in Guadeloupe or Martinique who have sickle cell anemia or SC-type sickle cell disease. It is a study without an assigned phase; it is not currently recruiting but is ongoing (active, not recruiting).

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Active, not recruiting

Sponsor

Centre Hospitalier Universitaire de la Guadeloupe

Intervention

HDL2

Start date

11/30/2022

Estimated completion

11/30/2027

Countries

Guadeloupe

Related genes

Locations

• Pointe-à-Pitre, Guadeloupe

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Aged from 18 years and over
* Be affected with Sickle cell anemia or SC sickle cell
* Living in French Caribbean Islands of Guadeloupe or Martinique and followed by physicians issued from a French West Indies Sickle Cell Reference or Competence Center
* At steady state in the last month (without acute complication)
* To have given a written consent after information on the study.

Exclusion Criteria:

* Other hemoglobinopathies than sickle cell disease
* Pregnancy or lactation
* Patient under judicial protection or without freedom
* Patient not affiliated with a social security system
* Patient hospitalized for transfusion or bleeding in the last 3 months